Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-13-005441
Filing Date
2013-05-07
Accepted
2013-05-07 18:26:32
Documents
1
Period of Report
2013-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5360
  Complete submission text file 0001437749-13-005441.txt   6756
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Issuer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1351 BRYANT COURT AMBLER PA 19002
Business Address
TERRERI PETER R (Reporting) CIK: 0001238456 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34263 | Film No.: 13821659